Punch & Associates Investment Management’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.9M Sell
600,913
-1,749
-0.3% -$55.1K 1.09% 29
2025
Q4
$17.8M Buy
602,662
+5,477
+0.9% +$152K 1.04% 34
2025
Q3
$15.1M Sell
597,185
-425
-0.1% -$10.4K 0.87% 43
2025
Q2
$14.3M Buy
597,610
+20,720
+4% +$480K 0.88% 43
2025
Q1
$13.2M Buy
576,890
+8,854
+2% +$214K 0.87% 39
2024
Q4
$14.4M Buy
568,036
+201,326
+55% +$5.1M 0.79% 41
2024
Q3
$9.14M Buy
366,710
+80,165
+28% +$2.37M 0.5% 84
2024
Q2
$8.5M Buy
+286,545
New +$7.95M 0.5% 87

Other funds holding RTO

Punch & Associates Investment Management's RTO Position: Q1 2026 in Review

Punch & Associates Investment Management reduced its Rentokil (RTO) stake by 0.29% in Q1 2026, selling an estimated $55.1K and leaving 600,913 shares worth $18.9M. The position accounts for 1.09% of the portfolio, ranked #29.

Punch & Associates Investment Management first reported a position in RTO in Q2 2024 and has held it in 8 quarters since. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Punch & Associates Investment Management held 600,913 shares of Rentokil worth $18.9M as of Q1 2026.
  • Punch & Associates Investment Management sold 1,749 Rentokil shares in Q1 2026, an estimated $55.1K.
  • Rentokil made up 1.09% of Punch & Associates Investment Management's portfolio in Q1 2026, its #29 holding.
  • Punch & Associates Investment Management first reported a position in Rentokil in Q2 2024 and has held it in 8 quarters since.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Punch & Associates Investment Management's 13F filing for Q1 2026, filed 15 May 2026.